menu search

BDX / Becton, Dickinson and Company (BDX) Q1 2023 Earnings Call Transcript

Becton, Dickinson and Company (BDX) Q1 2023 Earnings Call Transcript
Becton, Dickinson and Company (NYSE:BDX ) Q1 2023 Earnings Conference Call February 2, 2023 8:00 AM ET Company Participants Francesca DeMartino – Senior Vice President and Head-Investor Relations Tom Polen – Chairman, Chief Executive Officer and President Chris DelOrefice – Executive Vice President and Chief Financial Officer Dave Hickey – President-Life Sciences Segment Mike Garrison – President-Medical Segment Conference Call Participants Vijay Kumar – Evercore ISI Matt Taylor – Jefferies Larry Biegelsen – Wells Fargo Robbie Marcus – JPMorgan Matt Miksic – Barclays Rick Wise – Stifel Operator Hello, and welcome to BD's First Fiscal Quarter of 2023 Earnings Call. At the request of BD, today's call is being recorded, and a replay of the call will be made available on BD's Investor Relations website on bd.com. Read More
Posted: Feb 2 2023, 11:27
Author Name: Seeking Alpha
Views: 112256

BDX News  

Becton, Dickinson And HP Among 13 Companies Announcing Annual Dividend Increases In The First Half Of November

By Seeking Alpha
October 30, 2023

Becton, Dickinson And HP Among 13 Companies Announcing Annual Dividend Increases In The First Half Of November

Visa and Exxon Mobil announced dividend increases in October, with Visa increasing its dividend by 15.6% and Exxon Mobil increasing its dividend by 4. more_horizontal

Becton, Dickinson Stock Is A Hold, Here's Why

By Seeking Alpha
October 4, 2023

Becton, Dickinson Stock Is A Hold, Here's Why

Becton, Dickinson and Company is a global healthcare company specializing in medical supplies, devices, and diagnostic products. BDX saw solid growth more_horizontal

Here's Why You Should Hold BD (BDX) Stock in Your Portfolio

By Zacks Investment Research
September 19, 2023

Here's Why You Should Hold BD (BDX) Stock in Your Portfolio

BD's (BDX) slew of product launches raises optimism about the stock. more_horizontal

BD's (BDX) Tie-Up to Explore Flow Cytometry for Clinical Outcomes

By Zacks Investment Research
September 8, 2023

BD's (BDX) Tie-Up to Explore Flow Cytometry for Clinical Outcomes

BD's (BDX) latest partnership is likely to accelerate the delivery of innovative personalized therapies to patients who need them the most. more_horizontal

Beyond Pills: 3 Non-Pharma Healthcare Stocks for Healthy Gains

By InvestorPlace
August 30, 2023

Beyond Pills: 3 Non-Pharma Healthcare Stocks for Healthy Gains

When you consider healthcare stocks, do you automatically think of pharmaceutical companies? Most people do. more_horizontal

Becton Dickinson (BDX) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

By Zacks Investment Research
August 3, 2023

Becton Dickinson (BDX) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

Although the revenue and EPS for Becton Dickinson (BDX) give a sense of how its business performed in the quarter ended June 2023, it might be worth c more_horizontal

Becton Dickinson beats quarterly profit estimates on strong medical device sales

By Reuters
August 3, 2023

Becton Dickinson beats quarterly profit estimates on strong medical device sales

Becton Dickinson beat Wall Street estimates for third-quarter profit on Thursday, helped by strong demand for its drug delivery devices and surgical e more_horizontal

BD (BDX) Gears Up for Q3 Earnings: What's in the Offing?

By Zacks Investment Research
July 28, 2023

BD (BDX) Gears Up for Q3 Earnings: What's in the Offing?

Continued strength in BD's (BDX) Life Sciences segment's base business is expected to have benefited Q3 sales. more_horizontal


Search within

Pages Search Results: